Vincent Ossipow

Vincent Ossipow is a Partner at Omega Funds, a healthcare investment firm. He brings over 23 years of experience in life sciences investing, currently serving on the boards of multiple biotechnology companies, including Immunic Therapeutics since April 2019 and Sophia Genetics since June 2014. Previously, he worked as a Partner for Private Equity at Sectoral Asset Management and served as a research analyst and co-manager of the Pictet Biotech Fund at Pictet Bank. Before transitioning to the financial sector, he completed postdoctoral fellowships at Hoffman-La Roche and the National Cancer Institute, and worked as a research fellow at the University of Geneva from 2000 to 2006. Equipped with a Ph.D. in molecular biology and a CFA designation, Ossipow currently focuses on advancing clinical-stage biotechnology and healthcare investments across both public and private markets.